<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about HOLX</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Sat, 18 May 2013 05:59:10 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=HOLX" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/holx-beats-earnings-view-slashed-analyst-blog-cm244078">
      <guid isPermaLink="false">244078</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R3qVl3vRE6A/holx-beats-earnings-view-slashed-analyst-blog-cm244078</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>HOLX Beats Earnings, View Slashed - Analyst Blog</title>
      <description>Hologic Inc.  (  HOLX  ) reported  adjusted earnings per share of 35 cents in the second quarter of  fiscal 2013, higher than the year-ago earnings of 33 cents as well  as the company's&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/R3qVl3vRE6A" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 16:24:13 Z</pubDate>
      <a10:updated>2013-05-07T12:24:31Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/holx-beats-earnings-view-slashed-analyst-blog-cm244078</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/afterhours-earnings-report-for-may-6-2013-apc-paa-vno-holx-meli-ftr-fslr-mr-pra-pl-dpm-smg-cm243916">
      <guid isPermaLink="false">243916</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/siqlDExP3FE/afterhours-earnings-report-for-may-6-2013-apc-paa-vno-holx-meli-ftr-fslr-mr-pra-pl-dpm-smg-cm243916</link>
      <category>News Headlines</category>
      <category>Earnings</category>
      <title>After-Hours Earnings Report for May 6, 2013 :  APC, PAA, VNO, HOLX, MELI, FTR, FSLR, MR, PRA, PL, DPM, SMG</title>
      <description>The following companies are expected to report earnings after hours on 05/06/2013. Visit our  Earnings Calendar  for a full list of expected earnings releases.   Anadarko Petroleum Corporation  (&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/siqlDExP3FE" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 06 May 2013 22:00:04 Z</pubDate>
      <a10:updated>2013-05-06T18:22:14Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>APC</nasdaq:tickers>
      <nasdaq:tickers>DPM</nasdaq:tickers>
      <nasdaq:tickers>FSLR</nasdaq:tickers>
      <nasdaq:tickers>FTR</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>MELI</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>PAA</nasdaq:tickers>
      <nasdaq:tickers>PL</nasdaq:tickers>
      <nasdaq:tickers>PRA</nasdaq:tickers>
      <nasdaq:tickers>SMG</nasdaq:tickers>
      <nasdaq:tickers>VNO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/afterhours-earnings-report-for-may-6-2013-apc-paa-vno-holx-meli-ftr-fslr-mr-pra-pl-dpm-smg-cm243916</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/conceptus-beats-earnings-merger-announced-analyst-blog-cm242091">
      <guid isPermaLink="false">242091</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iKdcSJFajjA/conceptus-beats-earnings-merger-announced-analyst-blog-cm242091</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Conceptus Beats Earnings, Merger Announced - Analyst Blog</title>
      <description>Contraception device maker,  Conceptus Inc.  (  CPTS  ) reported earnings per share (EPS) of 5 cents in the first quarter of 2013, a massive improvement from a net loss of 9 cents per share in&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/iKdcSJFajjA" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 30 Apr 2013 17:54:11 Z</pubDate>
      <a10:updated>2013-04-30T14:55:13Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BAYRY</nasdaq:tickers>
      <nasdaq:tickers>CPTS</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/conceptus-beats-earnings-merger-announced-analyst-blog-cm242091</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/more-backing-for-holx-tomosynthesis-analyst-blog-cm237850">
      <guid isPermaLink="false">237850</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C8y828msscw/more-backing-for-holx-tomosynthesis-analyst-blog-cm237850</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>More Backing for HOLX Tomosynthesis - Analyst Blog</title>
      <description>Leading player in the women's health market  Hologic Inc.  (  HOLX  ) continues to leap forward with positive data supporting the adoption of its tomosynthesis technology. The company stated&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/C8y828msscw" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 17 Apr 2013 23:10:39 Z</pubDate>
      <a10:updated>2013-04-17T20:15:57Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CPHD</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/more-backing-for-holx-tomosynthesis-analyst-blog-cm237850</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/hologic-reiterated-at-neutral-analyst-blog-cm234735">
      <guid isPermaLink="false">234735</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KvWcZACwRvQ/hologic-reiterated-at-neutral-analyst-blog-cm234735</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Hologic Reiterated at Neutral - Analyst Blog</title>
      <description>On Apr 5, we reaffirmed our long-term Neutral recommendation on   Hologic  (  HOLX  ) as the numerous  headwinds in play might limit the growth prospects of the company.  This leading player in&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/KvWcZACwRvQ" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 08 Apr 2013 23:10:30 Z</pubDate>
      <a10:updated>2013-04-08T19:10:43Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CPHD</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/hologic-reiterated-at-neutral-analyst-blog-cm234735</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/traders-see-hologic-pullback-as-brief-cm234178">
      <guid isPermaLink="false">234178</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vBToPuTs9wE/traders-see-hologic-pullback-as-brief-cm234178</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Traders see Hologic pullback as brief</title>
      <description>Hologic dipped below $22 today, but traders apparently don't think that it will stay there long.    optionMONSTER's tracking programs detected the sale of more than 2,600 April 22 puts for $0.60&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/vBToPuTs9wE" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 05 Apr 2013 20:11:14 Z</pubDate>
      <a10:updated>2013-04-05T18:07:20Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/traders-see-hologic-pullback-as-brief-cm234178</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/holx-to-feature-innovative-products-analyst-blog-cm230575">
      <guid isPermaLink="false">230575</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/us-FxIGgrXk/holx-to-feature-innovative-products-analyst-blog-cm230575</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>HOLX to Feature Innovative Products - Analyst Blog</title>
      <description>Women's healthcare major  Hologic Inc.  (  HOLX  ) will showcase the benefits of its leading-edge 3D mammography systems at the 23rd Annual National Interdisciplinary Breast Cancer Conference&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/us-FxIGgrXk" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 25 Mar 2013 23:27:43 Z</pubDate>
      <a10:updated>2013-03-25T20:36:29Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABAX</nasdaq:tickers>
      <nasdaq:tickers>CPTS</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>NCBC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/holx-to-feature-innovative-products-analyst-blog-cm230575</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/hologic-offloads-lifecodes-biz-analyst-blog-cm230546">
      <guid isPermaLink="false">230546</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_ReBdbZT2-M/hologic-offloads-lifecodes-biz-analyst-blog-cm230546</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Hologic Offloads LIFECODES Biz - Analyst Blog</title>
      <description>Recently,  Hologic Inc.  (  HOLX  ) completed the divestment of its LIFECODES business unit to Immucor Inc., a prominent player in the automated instrument-reagent systems space in the blood&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/_ReBdbZT2-M" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 25 Mar 2013 22:25:56 Z</pubDate>
      <a10:updated>2013-03-25T19:29:34Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABAX</nasdaq:tickers>
      <nasdaq:tickers>CPTS</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/hologic-offloads-lifecodes-biz-analyst-blog-cm230546</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/after-hours-most-active-for-mar-5-2013-cx-hst-mtg-vod-bac-msft-yhoo-glw-sto-csco-holx-orcl-cm223737">
      <guid isPermaLink="false">223737</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X17dN9aNP18/after-hours-most-active-for-mar-5-2013-cx-hst-mtg-vod-bac-msft-yhoo-glw-sto-csco-holx-orcl-cm223737</link>
      <category>News Headlines</category>
      <category>After Hours Most Active</category>
      <title>After Hours Most Active for Mar 5, 2013 :  CX, HST, MTG, VOD, BAC, MSFT, YHOO, GLW, STO, CSCO, HOLX, ORCL</title>
      <description>The  NASDAQ 100 After Hours Indicator  is down -.07 to 2,799.18. The total After hours volume is currently 39,534,383 shares traded.    The following are the   most active stocks for the after&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/X17dN9aNP18" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 06 Mar 2013 02:45:04 Z</pubDate>
      <a10:updated>2013-03-05T22:04:43Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>BAC</nasdaq:tickers>
      <nasdaq:tickers>CSCO</nasdaq:tickers>
      <nasdaq:tickers>CX</nasdaq:tickers>
      <nasdaq:tickers>GLW</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>HST</nasdaq:tickers>
      <nasdaq:tickers>MSFT</nasdaq:tickers>
      <nasdaq:tickers>MTG</nasdaq:tickers>
      <nasdaq:tickers>ORCL</nasdaq:tickers>
      <nasdaq:tickers>STO</nasdaq:tickers>
      <nasdaq:tickers>VOD</nasdaq:tickers>
      <nasdaq:tickers>YHOO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/after-hours-most-active-for-mar-5-2013-cx-hst-mtg-vod-bac-msft-yhoo-glw-sto-csco-holx-orcl-cm223737</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/new-plan-for-hologics-mammography-analyst-blog-cm223093">
      <guid isPermaLink="false">223093</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J_PsTXiMRV4/new-plan-for-hologics-mammography-analyst-blog-cm223093</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>New Plan for Hologic's Mammography - Analyst Blog</title>
      <description>In an attempt to exhibit the benefits of 3D mammography (breast tomosynthesis) over conventional 2D mammography,  Hologic Inc.  (  HOLX  ) has planned to carry its 3D mammography in a new&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/J_PsTXiMRV4" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 04 Mar 2013 22:55:57 Z</pubDate>
      <a10:updated>2013-03-04T18:59:43Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>MDCI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/new-plan-for-hologics-mammography-analyst-blog-cm223093</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/after-hours-most-active-for-mar-1-2013-cers-siri-abt-sbgl-abbv-vod-bac-nok-qqq-amd-intc-holx-cm222651">
      <guid isPermaLink="false">222651</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K0iZ8FfeQUw/after-hours-most-active-for-mar-1-2013-cers-siri-abt-sbgl-abbv-vod-bac-nok-qqq-amd-intc-holx-cm222651</link>
      <category>News Headlines</category>
      <category>After Hours Most Active</category>
      <title>After Hours Most Active for Mar 1, 2013 :  CERS, SIRI, ABT, SBGL, ABBV, VOD, BAC, NOK, QQQ, AMD, INTC, HOLX</title>
      <description>The  NASDAQ 100 After Hours Indicator  is down -.84 to 2,746.91. The total After hours volume is currently 28,730,449 shares traded.    The following are the   most active stocks for the after&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/K0iZ8FfeQUw" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 02 Mar 2013 02:44:22 Z</pubDate>
      <a10:updated>2013-03-01T22:07:43Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>ABBV</nasdaq:tickers>
      <nasdaq:tickers>ABT</nasdaq:tickers>
      <nasdaq:tickers>AMD</nasdaq:tickers>
      <nasdaq:tickers>BAC</nasdaq:tickers>
      <nasdaq:tickers>CERS</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>INTC</nasdaq:tickers>
      <nasdaq:tickers>NOK</nasdaq:tickers>
      <nasdaq:tickers>QQQ</nasdaq:tickers>
      <nasdaq:tickers>SBGL</nasdaq:tickers>
      <nasdaq:tickers>SIRI</nasdaq:tickers>
      <nasdaq:tickers>VOD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/after-hours-most-active-for-mar-1-2013-cers-siri-abt-sbgl-abbv-vod-bac-nok-qqq-amd-intc-holx-cm222651</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/hologic-to-unveil-products-at-ecr-analyst-blog-cm221794">
      <guid isPermaLink="false">221794</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2BYJSIFYLCs/hologic-to-unveil-products-at-ecr-analyst-blog-cm221794</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Hologic to Unveil Products at ECR - Analyst Blog</title>
      <description>Leading provider of healthcare products for women  Hologic Inc.  (  HOLX  ) is scheduled to exhibit some of its newest offerings at the annual meeting of the European Society of Radiology,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/2BYJSIFYLCs" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 28 Feb 2013 00:20:01 Z</pubDate>
      <a10:updated>2013-02-27T20:35:53Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>MDCI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/hologic-to-unveil-products-at-ecr-analyst-blog-cm221794</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/lifes-products-gain-fda-approval-analyst-blog-cm216863">
      <guid isPermaLink="false">216863</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QFflpUuZ3eE/lifes-products-gain-fda-approval-analyst-blog-cm216863</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Life's Products Gain FDA Approval - Analyst Blog</title>
      <description>Global biotechnology tools company -  Life Technologies Corporation  (  LIFE  ) recently received 510(k) clearance from the US Food and Drug Administration ("FDA") for its 3500 Dx&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/QFflpUuZ3eE" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 12 Feb 2013 22:46:36 Z</pubDate>
      <a10:updated>2013-02-12T18:48:52Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>GSK</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>LIFE</nasdaq:tickers>
      <nasdaq:tickers>PGM</nasdaq:tickers>
      <nasdaq:tickers>RMD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/lifes-products-gain-fda-approval-analyst-blog-cm216863</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/solid-4q-for-conceptus-analyst-blog-cm216110">
      <guid isPermaLink="false">216110</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kJ2iZOU7Zuc/solid-4q-for-conceptus-analyst-blog-cm216110</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Solid 4Q for Conceptus - Analyst Blog</title>
      <description>Contraception device maker-  Conceptus Inc.  (  CPTS  ) reported earnings per share (EPS) of 17 cents during the fourth quarter of fiscal 2012, compared with a net loss of 8 cents per share in&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/kJ2iZOU7Zuc" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 11 Feb 2013 19:10:01 Z</pubDate>
      <a10:updated>2013-02-11T15:54:17Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ACHC</nasdaq:tickers>
      <nasdaq:tickers>CPTS</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>RMD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/solid-4q-for-conceptus-analyst-blog-cm216110</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/a-mixed-quarter-for-hologic-analyst-blog-cm215442">
      <guid isPermaLink="false">215442</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kJAYyFaL2FY/a-mixed-quarter-for-hologic-analyst-blog-cm215442</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>A Mixed Quarter for Hologic - Analyst Blog</title>
      <description>Hologic  (  HOLX  ) reported net income of $3.1 million or a penny per share in the first quarter of fiscal 2013 compared with $20.8 million or 8 cents per share in the year-ago quarter. After&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/kJAYyFaL2FY" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 08 Feb 2013 18:45:03 Z</pubDate>
      <a10:updated>2013-02-08T14:50:08Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>NVS</nasdaq:tickers>
      <nasdaq:tickers>RMD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/a-mixed-quarter-for-hologic-analyst-blog-cm215442</feedburner:origLink></item>
  </channel>
</rss>
